Lucid Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.

About LUCD

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. 

CEO
Lishan Aklog
CEOLishan Aklog
Employees
72
Employees72
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2018
Founded2018
Employees
72
Employees72

LUCD Key Statistics

Market cap
140.69M
Market cap140.69M
Price-Earnings ratio
-1.24
Price-Earnings ratio-1.24
Dividend yield
—
Dividend yield—
Average volume
1.74M
Average volume1.74M
High today
$1.36
High today$1.36
Low today
$1.27
Low today$1.27
Open price
$1.32
Open price$1.32
Volume
1.91M
Volume1.91M
52 Week high
$1.80
52 Week high$1.80
52 Week low
$0.6301
52 Week low$0.6301

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.